相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J. Joseph et al.
CIRCULATION (2022)
The Slow Path to Therapeutic Adherence
Francesco Ferrara et al.
HOSPITAL PHARMACY (2022)
Could Decreased Reporting of Suspected Adverse Reactions Generate Future Safety Concerns?
Francesco Ferrara et al.
HOSPITAL PHARMACY (2022)
Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes JACC Guideline Comparison
Michelle D. Kelsey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Pharmacotherapy of type 2 diabetes: An update and future directions
Antea DeMarsilis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Vaccines are in short supply amid global cholera surge
Kai Kupferschmidt
SCIENCE (2022)
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study
Francesco Ferrara et al.
CLINICAL DRUG INVESTIGATION (2022)
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETOLOGIA (2022)
Type 2 diabetes
Ehtasham Ahmad et al.
LANCET (2022)
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view
Francesco Ferrara et al.
INFLAMMOPHARMACOLOGY (2022)
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials (vol 372, m4573, 2021)
Palmer
BMJ-BRITISH MEDICAL JOURNAL (2022)
Cardiogenic Shock After Acute Myocardial Infarction A Review
Marc D. Samsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Medicines shortages and the perception of healthcare professionals working in hospitals: An Italian case study
Andrea Zovi et al.
Journal of Interprofessional Education and Practice (2021)
Regional Distribution of Cardiologists and Prescription Patterns of Sodium-Glucose Transporter-2 Inhibitors in Japan
Daisuke Inoue et al.
INTERNATIONAL HEART JOURNAL (2021)
Logistics management provides greater efficiency, governance and compliance
Francesco Ferrara et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map
Jianhong Zhu et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes A Systematic Review and Network Meta-analysis
Apostolos Tsapas et al.
ANNALS OF INTERNAL MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review
Olesya M. Taylor et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2020)
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
Stephanie A. Amiel et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
Brendan L. Neuen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Global perspectives on ensuring the safety of pharmaceutical products in the distribution process
Sohyun Jeong et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)